Pfizer Inc (PFE)
25.42
-0.27
(-1.05%)
USD |
NYSE |
Apr 17, 16:00
25.42
0.00 (0.00%)
Pre-Market: 20:00
Pfizer Total Return Level: 87.80 for April 16, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 16, 2024 | 87.80 |
April 15, 2024 | 88.55 |
April 12, 2024 | 88.38 |
April 11, 2024 | 90.02 |
April 10, 2024 | 89.95 |
April 09, 2024 | 91.53 |
April 08, 2024 | 90.84 |
April 05, 2024 | 91.12 |
April 04, 2024 | 91.08 |
April 03, 2024 | 93.03 |
April 02, 2024 | 94.16 |
April 01, 2024 | 94.74 |
March 28, 2024 | 94.84 |
March 27, 2024 | 94.94 |
March 26, 2024 | 94.29 |
March 25, 2024 | 93.75 |
March 22, 2024 | 93.51 |
March 21, 2024 | 94.53 |
March 20, 2024 | 94.67 |
March 19, 2024 | 94.43 |
March 18, 2024 | 94.74 |
March 15, 2024 | 95.49 |
March 14, 2024 | 96.14 |
March 13, 2024 | 96.45 |
March 12, 2024 | 95.73 |
Date | Value |
---|---|
March 11, 2024 | 96.96 |
March 08, 2024 | 93.03 |
March 07, 2024 | 91.56 |
March 06, 2024 | 92.93 |
March 05, 2024 | 89.13 |
March 04, 2024 | 88.48 |
March 01, 2024 | 90.88 |
February 29, 2024 | 90.77 |
February 28, 2024 | 92.41 |
February 27, 2024 | 91.90 |
February 26, 2024 | 92.89 |
February 23, 2024 | 94.88 |
February 22, 2024 | 94.16 |
February 21, 2024 | 94.57 |
February 20, 2024 | 94.29 |
February 16, 2024 | 94.40 |
February 15, 2024 | 94.02 |
February 14, 2024 | 92.65 |
February 13, 2024 | 92.18 |
February 12, 2024 | 94.53 |
February 09, 2024 | 94.19 |
February 08, 2024 | 94.23 |
February 07, 2024 | 94.19 |
February 06, 2024 | 93.99 |
February 05, 2024 | 90.81 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
78.39
Minimum
Mar 23 2020
190.93
Maximum
Dec 16 2021
122.55
Average
114.93
Median
Jun 12 2019
Total Return Level Benchmarks
Amgen Inc | 369.37 |
Gilead Sciences Inc | 91.54 |
Johnson & Johnson | 463.86 |
Viking Therapeutics Inc | 67.90 |
Moderna Inc | 103.80 |